Literature DB >> 12442327

NKT and T cells: coordinate regulation of NK-like phenotype and cytokine production.

Matthew J Loza1, Leonid S Metelitsa, Bice Perussia.   

Abstract

A maturation-dependent change in phenotype and cytokine production from relatively immature CD161(-) or CD161(+), IL-13(+)IL-4(+), IFN-gamma(-), to mature CD161(+)CD56(+) IFN-gamma(+) cells occurs in primary human alpha-galactosyl ceramide-reactive CD1d-restricted natural killer T (NKT) cells under the control of IL-12 and other monokines. Modulation of this process upon alpha-galactosyl ceramide stimulation explains the opposite roles of NKT cells to drive type 1 and type 2 immune responses. Because the same developmental changes occurred and were similarly regulated in T cells, the data establish that NKT cells should no longer be considered a functionally unique regulatory subset. However, the results of their analysis can be taken as a model for immunotherapeutic approaches with T cells for which a nominal or surrogate antigen is defined.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12442327     DOI: 10.1002/1521-4141(200212)32:12<3453::AID-IMMU3453>3.0.CO;2-D

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  22 in total

1.  Altered phosphorylated signal transducer and activator of transcription profile of CD4+CD161+ T cells in asthma: modulation by allergic status and oral corticosteroids.

Authors:  Yael Gernez; Rabindra Tirouvanziam; Khoa D Nguyen; Leonard A Herzenberg; Alan M Krensky; Kari C Nadeau
Journal:  J Allergy Clin Immunol       Date:  2007-10-24       Impact factor: 10.793

2.  CD56+ T cells inhibit HIV-1 infection of macrophages.

Authors:  Wei Hou; Li Ye; Wen-Zhe Ho
Journal:  J Leukoc Biol       Date:  2012-05-16       Impact factor: 4.962

3.  Changes in leucocyte and lymphocyte subsets during tuberculosis treatment; prominence of CD3dimCD56+ natural killer T cells in fast treatment responders.

Authors:  H Veenstra; R Baumann; N M Carroll; P T Lukey; M Kidd; N Beyers; C T Bolliger; P D van Helden; G Walzl
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

4.  IL-21 Selectively Protects CD62L+ NKT Cells and Enhances Their Effector Functions for Adoptive Immunotherapy.

Authors:  Ho Ngai; Gengwen Tian; Amy N Courtney; Soodeh B Ravari; Linjie Guo; Bin Liu; Jingling Jin; Elise T Shen; Erica J Di Pierro; Leonid S Metelitsa
Journal:  J Immunol       Date:  2018-08-15       Impact factor: 5.422

5.  Beta-agonists modulate T-cell functions via direct actions on type 1 and type 2 cells.

Authors:  Matthew J Loza; Susan Foster; Stephen P Peters; Raymond B Penn
Journal:  Blood       Date:  2005-11-08       Impact factor: 22.113

6.  Paucity of CD4+ natural killer T (NKT) lymphocytes in sooty mangabeys is associated with lack of NKT cell depletion after SIV infection.

Authors:  Namita Rout; James G Else; Simon Yue; Michelle Connole; Mark A Exley; Amitinder Kaur
Journal:  PLoS One       Date:  2010-03-24       Impact factor: 3.240

7.  Co-receptor choice by V alpha14i NKT cells is driven by Th-POK expression rather than avoidance of CD8-mediated negative selection.

Authors:  Isaac Engel; Kirsten Hammond; Barbara A Sullivan; Xi He; Ichiro Taniuchi; Dietmar Kappes; Mitchell Kronenberg
Journal:  J Exp Med       Date:  2010-04-19       Impact factor: 14.307

8.  Upregulation of SOCS-3 and PIAS-3 impairs IL-12-mediated interferon-gamma response in CD56 T cells in HCV-infected heroin users.

Authors:  Li Ye; Xu Wang; David S Metzger; Eric Riedel; Luis J Montaner; Wenzhe Ho
Journal:  PLoS One       Date:  2010-03-09       Impact factor: 3.240

9.  Asthma and gender impact accumulation of T cell subtypes.

Authors:  Matthew J Loza; Susan Foster; Eugene R Bleecker; Stephen P Peters; Raymond B Penn
Journal:  Respir Res       Date:  2010-07-28

10.  T-cells expressing natural killer (NK) receptors are altered in multiple sclerosis and responses to alpha-galactosylceramide are impaired.

Authors:  Joan O'Keeffe; Carol M Gately; Timothy Counihan; Michael Hennessy; Teresa Leahy; Anthony P Moran; Edward L Hogan
Journal:  J Neurol Sci       Date:  2008-08-15       Impact factor: 3.181

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.